fda remove semaglutide from shortage list As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Novo's Wegovy and Ozempic removed

Medicina (Buenos Aires)

Symptoms that you may experience are: Sweating Shaking Hunger Dizziness Blurred vision Confusion Fast heartbeat Some patients may need to reduce the dose of their insulin after they start Wegovy

Can I use Wegovy if I am pregnant or breastfeeding

Patients with Significant Liver Involvement: Those diagnosed with hepatic steatosis (fatty liver) or early-stage MASH, due to the potent anti-fat effects of the glucagon component on the liver

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain hematologic malignancies compared with insulin and metformin use, according to research published in JAMA Network Open

The dual action of tirzepatide might help overcome plateaus experienced with semaglutide